Ambey Laboratories Shares Surge 31.25% on NSE Post-IPO Listing

Team FS

    11/Jul/2024

Key Points:

Ambey Laboratories' shares were listed at Rs 85 on the NSE, a 25% premium over the IPO price.

The IPO was subscribed 106.59 times with a price band of Rs 65 to Rs 68.

The company raised Rs 12.70 crore from anchor investors ahead of the IPO.

Ambey Laboratories made a strong debut on the NSE, with its shares trading at Rs 89.25, marking a premium of 31.25% compared to the issue price of Rs 68. The stock was listed at Rs 85, reflecting a 25% premium over the initial public offering (IPO) price. The scrip is currently frozen at its upper limit of 5% over its listing price, indicating strong market demand.

The stock experienced a high of Rs 89.25 and a low of Rs 85 on the listing day, with about 20.86 lakh shares changing hands. The robust performance of Ambey Laboratories' shares is a testament to the company's solid market presence and investor confidence.

Ambey Laboratories' IPO, which opened for bidding on 4 July 2024 and closed on 8 July 2024, was a major success, being subscribed 106.59 times. The price band for the IPO was set between Rs 65 to Rs 68 per share. The issue included a fresh issuance of 62,58,000 shares and an offer for sale (OFS) of 3,12,000 shares by the existing promoter, resulting in a dilution of the promoter and promoter group shareholding from 94.97% to 69.90%.

The company plans to utilize the net proceeds from the IPO to meet working capital requirements, cover issue-related expenses, and for general corporate purposes. Ahead of the IPO, Ambey Laboratories raised Rs 12.70 crore from anchor investors on 3 July 2024, with the board allotting 18.68 lakh shares at Rs 68 per share to five anchor investors.

Ambey Laboratories is engaged in the manufacturing of agrochemical products for crop protection, including chemicals, compounds, herbal products, insecticides, pesticides, and fungicides. The company operates extensively across India and abroad, with its manufacturing facility located in Rajasthan, India. Ambey Laboratories collaborates within an interconnected network alongside Aromatic Rasayan Private and OFB Tech Private.

As of 31 January 2024, Ambey Laboratories employed 195 full-time employees. The company recorded revenue from operations of Rs 100.31 crore and a net profit of Rs 6.02 crore for the period ending on the same date.

The successful IPO and subsequent market performance highlight Ambey Laboratories' strong market positioning and growth potential in the agrochemical sector. Investors and market watchers will be keen to see how the company leverages this new capital to drive further growth and expansion in the future.

Also Read : SAHAJ SOLAR LIMITED IPO day 1: Check GMP Today, subscription status and review before applying

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX & Upstox.

Related News

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

onlyfans leakedonlyfan leaksonlyfans leaked videos